Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30412
Title: Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung Disease.
Austin Authors: Lok, Stacey D;Wong, Alyson W;Khor, Yet H ;Ryerson, Christopher J;Johannson, Kerri A
Affiliation: Department of Medicine, University of Saskatchewan, Saskatoon, Canada..
Faculty of Medicine, University of Melbourne, Melbourne, Australia..
Central Clinical School, Monash University, Melbourne, Australia..
Respiratory and Sleep Medicine
Department of Medicine, University of British Columbia, Vancouver, Canada..
Departments of Medicine and Community Health Sciences and Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canada..
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada..
Institute for Breathing and Sleep
Issue Date: Jun-2022
metadata.dc.date: 2021
Publication information: Chest 2022; 161(6): 1594-1597
URI: https://ahro.austin.org.au/austinjspui/handle/1/30412
DOI: 10.1016/j.chest.2021.12.636
ORCID: https://orcid.org/0000-0002-5434-9342
PubMed URL: 34921905
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/34921905/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Jul 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.